Market Overview

15 Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • Fortress Biotech Inc (NASDAQ: FBIO) shares rose 52.4 percent to $3.49 in pre-market trading after the company disclosed that a patient case study from the Phase 1 clinical trial of MB-101 for the treatment of glioblastoma will be published in the New England Journal of Medicine.
  • EnteroMedics Inc (NASDAQ: ETRM) rose 17.5 percent to $2.89 in pre-market trading after falling 14.11 percent on Wednesday.
  • FunctionX Inc (NASDAQ: FNCX) rose 10.5 percent to $3.37 in pre-market trading after surging 17.53 percent on Wednesday.
  • Prima BioMed Ltd (ADR) (NASDAQ: PBMD) rose 9.2 percent to $2.54 in pre-market trading after the company reported first clinical data from combination of IMP321 with Keytruda. The Database Safety Monitoring Board confirmed that IMP321 showed no safety concerns.
  • Christopher & Banks Corporation (NYSE: CBK) shares rose around 8.8 percent to $2.35 in pre-market trading after gaining 3.35 percent on Wednesday.
  • Cameco Corp (USA) (NYSE: CCJ) shares rose 7.4 percent to $11.00 in pre-market trading after dropping 2.06 percent on Wednesday.
  • Sears Holdings Corp (NASDAQ: SHLD) shares rose 7 percent to $8.75 in pre-market trading. Sears reported up to $200 million line of credit.
  • Northern Dynasty Minerals Ltd (NYSE: NAK) rose 5.5 percent to $2.29 in pre-market trading after declining 11.79 percent on Wednesday.
  • Live Ventures Inc (NASDAQ: LIVE) rose 4.7 percent to $28.99 in pre-market trading after gaining 6.09 percent on Wednesday.
  • Seadrill Ltd (NYSE: SDRL) rose 3.4 percent to $3.64 in pre-market trading after dropping 0.85 percent on Wednesday.
  • Galena Biopharma Inc (NASDAQ: GALE) shares rose 3.4 percent to $2.46 in pre-market trading after jumping 21.43 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Cempra Inc (NASDAQ: CEMP) fell 36.1 percent to $3.90 in pre-market trading after the company disclosed that it has received a Complete Response Letter from the FDA stating that solithromycin NDAs cannot be approved until safety information and manufacturing facility deficiencies are resolved.
  • NVIDIA Corporation (NASDAQ: NVDA) fell 3 percent to $106 in pre-market trading after dropping 6.88 percent on Wednesday.
  • Advanced Micro Devices, Inc. (NASDAQ: AMD) shares fell 2.6 percent to $11.25 in pre-market trading after declining 4.31 percent on Wednesday.
  • Conatus Pharmaceuticals Inc (NASDAQ: CNAT) shares fell around 2 percent to $5.20 in pre-market trading after tumbling 13.58 percent on Wednesday.
 

Related Articles (ETRM + FBIO)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers